The Biodynamics of Osseointegration Facts and Clinical Implications
LOD-207-00
Dr. Peter Schupbach
Dental implants are placed into the alveolar bone, with the expectation that they become osseointegrated and that the periimplant mucosa will heal to the abutment surface and fulfill the primary functions of the periodontal tissues, which are attachment and protection of the soft tissue and the underlying bone.<BR><BR>This requires that the rather rigid ankylotic like connection between implant and bone replaces functionally the sophisticated suspension via the periodontal ligament as offered by the evolution and, that the structural framework of the periimplant mucosa matches the architecture of the gingiva. <BR><BR>The context of an understanding of the elicited host site interfacial healing response will be reiterated for the time period immediately following implant placement up to long term behavior. The role of the implants
Unusual TMD Cases - Unusual Treatment
LOD-196-00
Dr. Ilia Roussou
In this lecture, we will discuss unusual Temporomandibular Disorders (TMD) cases and unusual treatments.<BR><BR>We will focus specifically on occlusion and how the relationship of the dental arches interacts with the stability of the Stomatognathic system.<BR><BR>Occlusion is one of the most demanding aspects of dentistry, we all know about the term occlusion confusion.<BR><BR>Although occlusion used to be the main etiological factor for Temporomandibular Disorders and many dental treatments were performed in order to address the pain symptoms, nowadays the literature suggest that the static relationship of the dental arches is rarely the etiological factor for an intracapsular TM joint disorders or a masticatory muscles disorders, In some cases though, were the occlusion compromises the orthopedic stability of the stomatognathic system, once the pain symptoms are treated the dental problem needs to be investigated as a possible etiological factor of the TMD symptoms.
Fixed Hybrid Prosthesis utilizing Zirconia - New Materials and Protocols
LOD-165-00
Dr. Stefano Conti
<p style="margin: 0px; text-align: justify;">This presentation will focus on a hybrid prosthesis, utilizing zirconia and the role of prosthetic gingiva in esthetic implant dentistry. <br /> </p> <p style="margin: 0px; text-align: justify;"><br /> </p> <p style="margin: 0px; text-align: justify;">We will see a pretty new treatment option that will give us the possibility to have complete control on the esthetic in a way that we have never been able to do before. <br /> </p> <p style="margin: 0px; text-align: justify;"><br /> </p> <p style="margin: 0px; text-align: justify;">Some the questions that we will answer in this presentation are: <br /> </p> <p style="margin: 0px; text-align: justify;"><br /> </p> <p style="margin: 0px; text-align: justify;">Why should we provide a hybrid prosthesis for our patients instead of a traditional one? <br /> </p> <p style="margin: 0px; text-align: justify;"><br /> </p> <p style="margin: 0px; text-align: justify;">Is this prosthetic option really predictable in achieving a natural esthetic for long term success? <br /> </p> <p style="margin: 0px; text-align: justify;"><br /> </p> <p style="margin: 0px; text-align: justify;">Which materials should we use Today, and why?</p>
Ridge Augmentation Using rhPDGF Growth Factors
LOD-121-00
Prof. Massimo Simion
This lecture covers the topic of ridge augmentation using the line of growthfactors termed rhPDGF (Gem-21) mixed with xenograft, TCP and autograft for implant placement. The scientific background and the first clinical cases are discussed and demonstrated. The new bone graft material shows to be an enhancement to the current technique of GBR.
Aspectos Biologicos em Implantes Unitarios (PORTUGUESE LANGUAGE ONLY)
LOD-073-00p
Dr. Mario Groisman
Aspectos Biologicos em Implantes Unitarios (PORTUGUESE LANGUAGE ONLY)
Clinical Pharmacology - What Every Dentist Should Know
LOD-072-00
Dr. Anthony Feck
Modern dentistry has expanded the arsenal of services to restore patients oral health and cosmetic needs like never before. These changes have corresponded to an increasingly complex medical environment where patients are presenting at a more advanced age, with more medical conditions, and taking more medications. Understanding the pharmacology as it relates to their systems and how the drugs they are taking, as well as those we intend to administer affect the patient, one another, and our planned treatment is necessary for a safe and successful outcome to our planned care.
Treating the Medically Complex Patient
LOD-069-00
Dr. Adi Garfunkel
• What is the dental-medical approach to the hypertensive patient?<br> • Could we treat patients with medication induced bleeding tendency?<br> • The use of adrenalin in local anesthesia constitutes at times a contradictory subject. How do we deal with this question?<br>
YSGG Laser Precision in Periodontal Plastic Surgery
LOD-059-00
Dr. Bobby Butler
Lasers have been used in dentistry for many years. Mostly they have been used with soft tissue procedures. Recently the Er,Cr:YSGG laser has been shown to be safe and effective in osseous procedures. Many cosmetic dentists have been using lasers for esthetic crown lengthening procedures, but most of these cases are simple gingivectomies and not true crown lengthening procedures. Complications can occur without understanding the biologic width and different periodontal biotypes. This presentation will discuss current and future applications with the Er, Cr: YSGG laser with periodontal surgical procedures. The focus will be its use in closed and open esthetic crown lenghtening procedures. Discussion with case selection and osseous biotypes with be stressed. Other applications involving osseous augmentation procedures, harvesting osseous blocks, ridge splitting and lateral sinus wall procedures, will also be briefly discussed.
Bone Morphogenetic Proteins, A Realistic Alternative to Bone Grafting<br>
LOD-054-00
Dr. Ulf Wikesjo
Surgical placement of oral implants is governed by the prosthetic design and by the morphology and quality of the alveolar bone. Often, implant placement may be difficult, if at all possible, due to alveolar ridge aberrations. In consequence, prostheticly dictated implant positioning commonly entails bone augmentation procedures. One objective of our laboratory is to evaluate the biologic and clinical potential of bone morphogenetic proteins (BMPs) including rhBMP-2, rhOP-1/rhBMP-7, rhGDF-5, other candidate biologics, bone biomaterials, and devices for alveolar ridge augmentation and implant fixation. This presentation will discuss the unique biologic potential, the clinical relevance and perspectives of BMP technologies for alveolar bone augmentation and oral implant fixation, in particular the development of a unique bone-inductive oral implant. This presentation will also address merits and explain short-comings of current treatment protocol including bone biomaterials and guided bone regeneration (GBR). BMPs have an unparalleled potential to augment alveolar bone and support implant osseointegration and long-term functional loading. Inclusion of BMPs for alveolar augmentation and osseointegration will not only enhance predictability of existing clinical protocol but radically change current treatment paradigms. Inclusion of the bone-inductive oral implant in the treatment panorama may make 'grafting' and GBR procedures altogether obsolete.